ArticleScientific reports2023

Factors affecting the ORR after neoadjuvant therapy of TP regimen combined with PD-1 inhibitors for esophageal cancer.

Rulan Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.